SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Felicity Liew, Shubha Talwar, Andy Cross, Brian J Willett, Sam Scott, Nicola Logan, Matthew K Siggins, Dawid Swieboda, Jasmin K Sidhu, Claudia Efstathiou, Shona C Moore, Chris Davis, Noura Mohamed, Jose Nunag, Clara King, A A Roger Thompson, Sarah L Rowland-Jones, Annemarie B Docherty, James D Chalmers, Ling-Pei HoAlexander Horsley, Betty Raman, Krisnah Poinasamy, Michael Marks, Onn Min Kon, Luke Howard, Daniel G Wootton, Susanna Dunachie, Jennifer K Quint, Rachael A Evans, Louise V Wain, Sara Fontanella, Thushan I de Silva, Antonia Ho, Ewen Harrison, J Kenneth Baillie, Malcolm G Semple, Christopher Brightling, Ryan S Thwaites, Lance Turtle, Peter J M Openshaw, ISARIC4C Investigators, Cherie Armour, G. Carson, J. Busby, B. Connolly, J. Cooper, S. Drain, D. Grieve, N. Hart, M. Harvey, L. G. Heaney, J. Hughes, M. G. Jones, N. Magee, A. McArdle, L. McGarvey, C. Mills, J. Mitchell, T. Peto, N. Powell, M. Rowland, M. Sharma, S. Siddiqui

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination'. Together they form a unique fingerprint.

Immunology and Microbiology

Medicine and Dentistry